A physician and scientist focused on neurodegenerative diseases, Dr Cashman is recognized worldwide as pioneering the emerging fields of prion biology and protein misfolding diseases, in particular, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). His first academic posting was at Montreal Neurological Institute and Hospital of McGill University. From 1998 to 2005, he was the Diener Professor of Neurodegenerative Diseases at the University of Toronto. In 2005, he moved to the University of British Columbia, where he holds the Canada Research Chair in Neurodegeneration and Protein Misfolding Diseases and serves as Director of the UBC ALS Centre. He’s received more than $50 million in research grant funding from the CIHR, CRC, NCE, NIH and various corporations for his work involving protein misfolding and prion technologies. He was awarded the Jonas Salk Prize for biomedical research in 2000 and was elected a Fellow of the Canadian Academy of Health Sciences in 2008.